|
We the manufacturer of the device performed our own investigation, based on the data and pictures disclosed by the us importer which are the following: the actual medical device involved in the even has been evaluated in date may the 19th 2022 and found to be working properly within specifications.Service field technician performed tests with the same handpiece used for the treatment (7mm) and found the device working properly within specifications.To follow-up on the investigation cynosure (us importer) contacted the site in order to have more detailed information about the patient's state of healing.New pictures of the patient's lesion has been disclosed in which the blisters developed to a lesion that can lead to a permanent scar.The treatment's parameters has been evaluated and found correct relative to the patient's conditions and intended treatment.Anyway it is possible to assume that the practitioner who performed the treatment made several passes on the same area causing the skin to receive too much energy and caused the burns.Patient was treated with over the counter products for infection prevention (peroxide and polysprine) blisters and scars are foreseeable side effect of the treatment as specified on the operator's manual code (b)(4) (actual revision shipped with the device) at chapter "adverse effects".The actual cause of the event has been determined to be a user error in which the practitioner performed multiple passes on the same area delivering an excessive amount of energy to the patient's skin.Due to the fact that the device has been found working properly within specifications and that no design deficiency has arisen, no corrective action has been implemented.The present initial report has to be considered as a final report unless fda has further questions.
|
|
On june the 5th 2023, el.En.Electronic engineering spa became aware of an adverse event, reported by the us importer, cynosure, in which it is stated that a patient developed blisters and burns following a vascular treatment performed with the elite iq laser medical device.The actual device involved in the event is an elite iq laser medical device ref: m122b1, s/n: (b)(6), udi: (b)(4).The actual device invovled in the event is manufactured by el.En.Electronic engineering spa and marketed in the us with 510(k) k193426.Based on the narrative provided by the us importer, cynosure, it is reported that a female patient reported to have got blisters following a treatment, on the lower leg, performed with the device elite iq for spider veins (vascular treatment).Based on the pictures made available of the patient's lesion, it is possible to see that the blisters have developed to wounds that could possibly evolve in permanent scarring.The actual device involved in this event has been evaluated in date (b)(6) 2023 in which the device has been found to be working properly within specifications.We, the manufacturer of device, became aware of the event on june the 5th 2023 by specific communication of the us importer, cynosure, and evaluated the event reportable because, according to fda 21 cfr 803 this event represent a serious injury (probable permanent scar) and is a reportable event.Moreover, the us importer cynosure, already evaluated the event as reportable (for the same reason) and proceeded to submit their own mdr report code mdr 12222993-2023-00005 in date june the 8th, 2023.Based on that, in accordance to 21 cfr part 803.50(3), we as manufacturer of the device proceeded to submit our own mdr report in order to submit all the missing information.
|